VRX vs. PRGO for CEO

In this video

Share

VRX vs. PRGO for CEO

CNBC's Meg Tirrell reports on the possibility of Perrigo CEO Joseph Papa heading over to Valeant, as well as biotech firm Interxon feeling some pressure after the release of a report calling it 'the new Theranos.'
04:32
Fri, Apr 22 20163:16 PM EDT